期刊
BIOCONJUGATE CHEMISTRY
卷 18, 期 5, 页码 1361-1365出版社
AMER CHEMICAL SOC
DOI: 10.1021/bc700230m
关键词
-
类别
资金
- NCI NIH HHS [CA 42238] Funding Source: Medline
Novel estrogen-conjugated pyridine-containing Gd(III) and Eu(Ill) contrast agents (EPTA-Gd/Eu) were designed and effectively synthesized. Convenient to administration and MRI experiments, both EPTA-Gd and EPTA-Eu are soluble in water. The EPTA-Gd selectively binds with a micromolar affinity to the estrogen receptor and induces proliferation of human breast cancer cells. The EPTA-Gd is not lethal and does not cause any adverse effects when administrated intravenously. It enhances T-1 and T-2 nuclear relaxation rates of water and serves as a selective contrast agent for localizing the estrogen receptor by MRI.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据